Interventing mitochondrial PD-L1 suppressed IFN-γ-induced cancer stemness in hepatocellular carcinoma by sensitizing sorafenib-induced ferroptosis-Reference-Cited by-同舟云学术

Interventing mitochondrial PD-L1 suppressed IFN-γ-induced cancer stemness in hepatocellular carcinoma by sensitizing sorafenib-induced ferroptosis

Published:2024-02 Issue: Volume:212 Page:360-374
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Li Ting,Huang Hai-Yan,Qian Bo,Wang Wei-Hua,Yuan Qi,Zhang Han-Yu,He Jie,Ni Ke-Jian,Wang Pan,Zhao Zhuo-Ying,He Jun-Lin,Fu Shi-Wei,Xu Ling,Lin Yu-Chun,Lin Zhong-Ning^ORCID

Publisher

Elsevier BV

Reference76 articles.

1. Hepatocellular carcinoma;Vogel;Lancet,2022

2. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: promises and Challenges;Paskeh;Pharmacol. Res.,2023

3. Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma;Byun;J. Exp. Clin. Cancer Res.,2022

4. Downregulation of mitochondrial cyclooxygenase-2 inhibits the stemness of nasopharyngeal carcinoma by decreasing the activity of dynamin-related protein 1;Zhou;Theranostics,2017

5. Parthenolide inhibits cancer stem-like side population of nasopharyngeal carcinoma cells via suppression of the NF-kappaB/COX-2 pathway;Liao;Theranostics,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell life-or-death events in osteoporosis: All roads lead to mitochondrial dynamics;Pharmacological Research;2024-10

2. Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy;Frontiers in Immunology;2024-09-09

3. Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects;Apoptosis;2024-07-15

4. The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma;Frontiers in Immunology;2024-05-29